Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Hepatology. 2012 Aug 21;56(4):1311–1318. doi: 10.1002/hep.25805

Table 2.

Cross-sectional Correlates of Adipo-IR at Baseline and at 96 weeks

Correlates at baseline or 96 weeks Baseline Adipo-IR Adipo-IR at 96 weeks
Estimated ratio of
Adipo-IR
(95% CI)
P* Estimated ratio of
Adipo-IR
(95% CI)
P
Demographics
 Female vs. Male 1.13 (0.79, 1.61) 0.50 2.06 (1.40, 3.03) <0.001
 Hispanic vs. other ethnicities 1.16 (0.89, 1.50) 0.27 1.09 (0.80, 1.50) 0.56
 Age at Randomization 1.00 (0.99, 1.01) 0.68 0.999 (0.988, 1.010) 0.89
Anthropometrics
 BMI (kg/m2) 1.06 (1.02, 1.09) 0.001 1.05 (1.01, 1.08) 0.004
 Waist circumference (cm) 0.99 (0.98, 1.00) 0.12 1.01 (1.00, 1.02) 0.05
 Total body fat (%) 1.02 (0.99, 1.04) 0.16 0.98 (0.96, 1.00) 0.12
Laboratory measures
 AST (U/L) 0.998 (0.993, 1.003) 0.46 1.00 (0.99, 1.01) 0.92
 ALT (U/L) 1.001 (0.998, 1.004) 0.39 1.004 (0.999, 1.008) 0.08
 Glucose (mg/dl) 1.01 (1.00, 1.02) 0.001 1.01 (1.00, 1.02) 0.001
 Triglycerides (mg/dl) 1.00 (1.00, 1.00) 0.62 1.00 (1.00, 1.00) 0.96
 Total cholesterol (mg/dl) 1.002 (0.999, 1.005) 0.17 1.004 (1.001, 1.008) 0.03
 HDL cholesterol (mg/dl) 0.997 (0.988, 1.006) 0.46 0.995 (0.981, 1.004) 0.29
Histology
 Fibrosis score: 3–4 vs. <3 1.33 (1.05, 1.69) 0.02 1.03 (0.74, 1.41) 0.88
 Steatosis Grade 2–3 vs. 0–1 1.21 (0.96, 1.51) 0.10 0.99 (0.75, 1.31) 0.93
 Lobular inflammation >2 foci vs. 0–2 foci 1.02 (0.80, 1.28) 0.89 1.08 (0.78, 1.50) 0.63
 Ballooning: Many vs. None/Few 1.16 (0.93, 1.45) 0.20 0.99 (0.72, 1.37) 0.97
 NAS>=5 vs. <5 0.91 (0.68, 1.21) 0.52 1.00 (0.66, 1.52) 1.00
Resolution of NASH - - 0.74 (0.56, 0.98) 0.03
*

P values were from multiple linear regression model, regressing the logarithm of Adipo-IR at baseline on the listed correlates at baseline.

P values were from multiple linear regression model, regressing the logarithm of Adipo-IR at 96 weeks on the listed correlates at 96 weeks.

Abbreviations: BMI, body mass index; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDL, low-density lipoprotein; Adipo-IR, adipose tissue insulin resistance; NAS, NAFLD activity score; NASH, nonalcoholic steatohepatitis.